Indivior PLC
(FRA:2IVB)
€
9.8
0.2 (2.08%)
Market Cap: 1.21 Bil
Enterprise Value: 1.18 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 63/100 Indivior PLC at Jefferies Healthcare Conference Transcript
Jun 07, 2023 / 07:00PM GMT
Release Date Price:
€18.96
(+2.93%)
James Vane;Tempest
(Trades, Portfolio), Inc. - Moderator
Good afternoon, everybody. My name is James Vane-Tempest. I'm Jefferies' European specialty pharma analyst. I'm delighted to be up here with Indivior and Mark Crossley as CEO. He's going to give a presentation, there might be some time for some Q&A at the end. So with that, I'll hand it to Mark and look forward to the presentation.
Mark Crossley
Indivior PLC - CEO
Thanks, James. I'll just have my water here, just with all the air quality that we have going on in New York today. I'm Mark Crossley, I'm the CEO of Indivior. As we progress through, I'm going to assume that the forward-looking statements have been read.
What I'd like to start with for folks that aren't as
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot